Form D Explorer
Dewpoint Therapeutics, Inc. · CIK 1828893

Report a data issueCitable research briefCompare issuerPrivate research collection

Dewpoint Therapeutics, Inc.

CIK 1828893 · Corporation · Inc. DELAWARE · BOSTON, Massachusetts · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
1
Amendments
1
Activity
Sep 23, 2025
through Jul 13, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldSep 23, 2025 · DJul 13, 2026 · D/ALater minus earlier
Reported offering amount$59,124,298$82,299,400$23,175,102
Reported amount sold$59,124,298$77,164,102$18,039,804
Reported investor count—23—
Reported minimum investment$0$0$0

Earlier SEC source: 0001828893-25-000002 · Later SEC source: 0001828893-26-000001

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · Jul 13, 2026

Reported offering amount
$82,299,400
Reported exemptions
Rule 506(b)
Reported amount sold
$77,164,102

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (2)